Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Women express low decision regret after preimplantation testing for aneuploidy

Key clinical point: When rating decision regret for undergoing preimplantation genetic testing for aneuploidy, the mean score was 8.5 out of 100.

Major finding: Of patients undergoing preimplantation genetic testing for aneuploidy, 61% experienced no regret.

Study details: Survey of 69 patients undergoing preimplantation genetic testing for aneuploidy.

Disclosures: There was no external funding. One coauthor declared personal fees and other support from the fertility and pharmaceutical sector. No other conflicts of interest were declared.

Citation:

Goldman KN et al. Hum Reprod. 2019 Jun 21. doi: 10.1093/humrep/dez080.